Drug Database
Back to search

Belgium· BE-AMP-SAM123051-00

Kerlone 20 mg

A betaxolol product containing betaxolol hydrochloride, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 8 of our 19 countries.

ATC C07AB05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKerlone 20 mgATCC07AB05REGISTER NO.BE-AMP-SAM123051-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betaxolol hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Betaxolol is registered in 8 of 19 countries.

Countries holding a registration under ATC C07AB05 (betaxolol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search betaxolol products by name

Betaxolol · ATC C07AB05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Germany
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Betaxolol Hydrochloride
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
C07AB05
ATC class
Betaxolol
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0829432

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

223 interactions on record for betaxolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check betaxolol against other medicinesHow interaction checks work

Betaxolol · interactions on record

223 records

  • 11 severe
  • 184 moderate
  • 20 minor
  • 8 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Betaxolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betaxolol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Betoptic S
  • Bulgaria · Бетак, Бетоптик S
  • Cyprus · Betac
  • Czechia · Betamed, Betaxolol Medreg
  • Germany · Betoptima, Kerlone
  • Denmark · Betoptic S
  • Estonia · Betoptic S
  • Spain · Betoptic
  • Finland · Betoptic, Betoptic S
  • France · Betaxolol Biogaran, Betaxolol Eg
  • United Kingdom (Northern Ireland) · Betoptic
  • Greece · Betoptic, Betoptic S
  • Croatia · Betoptic
  • Hungary · Betoptic, Lokren
  • Italy · Betoptic, Kerlon
  • Lithuania · Betac, Betaxolol Pmcs
  • Luxembourg · Betoptic, Betoptic S
  • Latvia · Betac, Betaxolol Pmcs
  • Netherlands · Betoptic S
  • Norway · Betoptic, Betoptic S
  • Poland · Betaxolol Medreg, Betaxolol Pmcs
  • Portugal · Bertocil, Betoptic
  • Romania · Betaxolol Gemax Pharma, Betoptic S
  • Sweden · Betoptic, Betoptic S
  • Slovenia · Betoptic, Betoptic S
  • Slovakia · Betac, Betaxolol Medreg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b70982f4-3439-4c96-bd8f-b727a17cdce5
GET /v1/drugs/b70982f4-3439-4c96-bd8f-b727a17cdce5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Kerlone 20 mg",
  "name_fr": "Kerlone 20 mg",
  "name_nl": "Kerlone 20 mg",
  "amp_code": "SAM123051-00",
  "strengths": [
    "20.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Betaxolol Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Betaxolol",
  "authorisation_numbers": [
    "BE123051"
  ]
}
API referenceMCP serverPlans

See everything about betaxolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console